Concepedia

Katia Mazzocco

KM

40

Publications

1.8K

Citations

26

H-Index

1994

Active since

Affiliations

Istituto Giannina Gaslini(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

St Anna Children's Hospital

University of Padua

Institut Curie

Katia Mazzocco is an author at Istituto Giannina Gaslini specializing in medicine, pathology, and tumor biology.

ORCID

Top concepts

Publications per year

1994–2021

40

Publications

40

Expression of ΔNp73 is a molecular marker for adverse outcome in neuroblastoma patients

Ida Casciano, Katia Mazzocco, Luca Boni et al. · Cell Death and Differentiation · 2002 · 177 citations

, , +6

Quality Assessment of Genetic Markers Used for Therapy Stratification

I.M. Ambros, Jean Bénard, Maria Guida Boavida et al. · Journal of Clinical Oncology · 2003 · 123 citations

MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.

Gian Paolo Tonini, Luca Boni, Andrea Pession et al. · Journal of Clinical Oncology · 1997 · 111 citations

Comprehensive Genetic and Histopathologic Study Reveals Three Types of Neuroblastoma Tumors

Maria Łastowska, C. Cullinane, S. Variend et al. · Journal of Clinical Oncology · 2001 · 105 citations

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)

Gudrun Schleiermacher, Jean Michon, Agnès Ribeiro et al. · British Journal of Cancer · 2011 · 98 citations · Full text

Rows per page

1–5 of 40